PH30476A - Risperidone pamoate - Google Patents

Risperidone pamoate

Info

Publication number: PH30476A
Authority: PH; Philippines
Prior art keywords: pct; risperidone; sec; compositions; compound
Prior art date: 1993-04-28

Application number

PH48074A

Other languages

English (en)

Inventor

Mesens Jean Louis

Peeters Josef

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-04-28

Filing date

1994-04-08

Publication date

1997-05-28

1994-04-08 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

1997-05-28 Publication of PH30476A publication Critical patent/PH30476A/en

Links

RAPZEAPATHNIPO-UHFFFAOYSA-N risperidone Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCCCC4=NC=3C)=NOC2=C1 RAPZEAPATHNIPO-UHFFFAOYSA-N 0.000 title abstract 2
229960001534 risperidone Drugs 0.000 title abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
239000002253 acid Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
- C07C65/105—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic
- C07C65/11—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic with carboxyl groups on a condensed ring system containing two rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Life Sciences & Earth Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Biomedical Technology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Saccharide Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

PH48074A 1993-04-28 1994-04-08 Risperidone pamoate PH30476A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP93201216		1993-04-28

Publications (1)

Publication Number	Publication Date
PH30476A true PH30476A (en)	1997-05-28

Family

ID=8213799

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PH48074A PH30476A (en)	1993-04-28	1994-04-08	Risperidone pamoate

Country Status (31)

Country	Link
US (2)	US5612346A (de)
EP (1)	EP0697019B1 (de)
JP (1)	JP3478397B2 (de)
KR (1)	KR100307101B1 (de)
CN (1)	CN1041727C (de)
AT (1)	ATE163418T1 (de)
AU (1)	AU675136B2 (de)
BG (1)	BG62004B1 (de)
CA (1)	CA2160366C (de)
CY (1)	CY2107B1 (de)
CZ (1)	CZ286688B6 (de)
DE (1)	DE69408666T2 (de)
DK (1)	DK0697019T3 (de)
ES (1)	ES2113652T3 (de)
FI (1)	FI109125B (de)
GR (1)	GR3026028T3 (de)
HU (1)	HU218212B (de)
IL (1)	IL109448A (de)
LV (1)	LV12315B (de)
NO (1)	NO305083B1 (de)
NZ (1)	NZ266143A (de)
PH (1)	PH30476A (de)
PL (1)	PL182466B1 (de)
RO (1)	RO115955B1 (de)
RU (1)	RU2131428C1 (de)
SG (1)	SG47046A1 (de)
SI (1)	SI9420031B (de)
SK (1)	SK280589B6 (de)
TW (1)	TW376319B (de)
WO (1)	WO1994025460A1 (de)
ZA (1)	ZA942909B (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1074923C (zh)	1993-11-19	2001-11-21	詹森药业有限公司	微囊密封的3-哌啶基取代的1,2-苯并异唑类和1,2-苯并异噻唑类
US5453425A (en) *	1994-07-11	1995-09-26	Janssen Pharmaceutica N.V.	Risperidone oral formulation
TW487572B (en) *	1996-05-20	2002-05-21	Janssen Pharmaceutica Nv	Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
US6617321B2 (en)	1997-09-30	2003-09-09	Eli Lilly And Company	2-methyl-thieno-benzodiazepine formulation
US6169084B1 (en) *	1997-09-30	2001-01-02	Eli Lilly And Company	2-methyl-thieno-benzodiazepine formulation
UA72189C2 (uk) *	1997-11-17	2005-02-15	Янссен Фармацевтика Н.В.	Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
HK1041199B (en) *	1998-09-30	2005-03-18	Eli Lilly & Company	2-Methyl-thiophenone-benzodiazine formula
WO2000027849A2 (en) *	1998-11-12	2000-05-18	Merck & Co., Inc.	Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same
FR2802101B1 (fr)	1999-12-10	2003-02-28	Aventis Pharma Sa	Association de cymemazine et d'un neuroleptique atypique
US6770478B2 (en) *	2000-02-10	2004-08-03	The Regents Of The University Of California	Erythrocytic cells and method for preserving cells
US6495164B1 (en) *	2000-05-25	2002-12-17	Alkermes Controlled Therapeutics, Inc. I	Preparation of injectable suspensions having improved injectability
WO2002043766A1 (en) *	2000-11-29	2002-06-06	Takeda Chemical Industries, Ltd.	Medicinal compositions and process for producing the same
US20050232995A1 (en)	2002-07-29	2005-10-20	Yam Nyomi V	Methods and dosage forms for controlled delivery of paliperidone and risperidone
NZ570198A (en) *	2002-07-29	2010-01-29	Alza Corp	Methods and dosage forms for controlled delivery of paliperidone or risperidone
AU2003250472A1 (en) *	2002-08-23	2004-03-11	Ranbaxy Laboratories Limited	Stable aqueous solutions of risperidone and methods for their preparation
KR20040034996A (ko) *	2002-10-18	2004-04-29	한미약품 주식회사	리스페리돈의 개선된 제조방법
WO2004094414A1 (en) *	2003-04-22	2004-11-04	Synthon B.V.	Water soluble salts of risperidone
RU2249456C1 (ru) *	2003-07-15	2005-04-10	Боев Игорь Викторович	Способ комбинированного купирования шизоаффективных синдромов психотического и субпсихотического уровня в условиях дневного стационара
US6987111B2 (en) *	2003-08-06	2006-01-17	Alkermes Controlled Therapeutics, Ii	Aripiprazole, olanzapine and haloperidol pamoate salts
UA82561C2 (uk) *	2003-10-23	2008-04-25	Оцука Фармасьютикалз Ко., Лтд.	Стерильна ін'єкційна композиція арипіпразолу з контрольованим вивільненням, спосіб її виготовлення та спосіб лікування шизофренії
US7884096B2 (en) *	2003-12-02	2011-02-08	Pharmaneuroboost N.V.	Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
EP1708790B1 (de) *	2003-12-02	2010-04-21	PharmaNeuroBoost N.V.	Verwendung von pipamperon und einem d2-rezeptor antagonisten oder einem serotonin/dopamin antagonisten zur behandlung von psychotischen störungen
EP1715843A1 (de) *	2004-01-29	2006-11-02	Neuromolecular Inc.	Kombination eines nmda-rezeptor-antagonisten und eines mao-hemmers oder eines gadph-hemmers zur behandlung von erkrankungen im zusammenhang mit dem zentralen nervensystem
SI1838716T1 (sl) *	2005-01-05	2011-10-28	Lilly Co Eli	Olanzapin pamoat dihidrat
EP1695973A1 (de) *	2005-02-24	2006-08-30	Neuro3D	Ocaperidonsalz und dieser enthaltende pharmazeutische Zubereitung
AR055099A1 (es) *	2005-07-28	2007-08-08	Alza Corp	Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol
CA2622758A1 (en) *	2005-09-15	2007-03-29	Elan Pharma International, Limited	Nanoparticulate aripiprazole formulations
US8852638B2 (en)	2005-09-30	2014-10-07	Durect Corporation	Sustained release small molecule drug formulation
ES2562878T3 (es)	2007-05-25	2016-03-08	Indivior Uk Limited	Formulaciones de liberación sostenida de compuestos de risperidona
SI2170279T1 (en) *	2007-07-31	2018-04-30	Otsuka Pharmaceutical Co., Ltd.	Methods for producing aripiprazole suspension and freeze-dried formulation
KR102318070B1 (ko) *	2007-12-19	2021-10-27	얀센 파마슈티카 엔.브이.	장기 작용성 주사가능 팔리페리돈 에스테르와 관련된 투여 요법
HUE065359T2 (hu)	2011-03-18	2024-05-28	Alkermes Pharma Ireland Ltd	Szorbitán-észtereket tartalmazó gyógyászati készítmények
HUE028159T2 (en) *	2011-04-26	2016-12-28	Torrent Pharmaceuticals Ltd	Acid addition salts of risperidone and pharmaceutical compositions containing them
JP6219918B2 (ja)	2012-03-19	2017-10-25	アルカームスファーマアイルランドリミテッド	グリセロールエステルを含む医薬組成物
ES2765036T3 (es)	2012-03-19	2020-06-05	Alkermes Pharma Ireland Ltd	Composiciones farmacéuticas que comprenden esteres de ácidos grasos
ES2950418T3 (es) *	2012-03-19	2023-10-09	Alkermes Pharma Ireland Ltd	Composiciones farmacéuticas que comprenden alcohol bencílico
EP2833866B2 (de)	2012-04-04	2024-11-27	Intervet International B.V.	Weiche, kaufähige pharmazeutische produkte
CN102659577B (zh) *	2012-04-07	2014-07-02	安徽绩溪县徽煌化工有限公司	一种亚甲基双羟基萘酸的制备方法
EP2897592B1 (de)	2012-09-19	2020-02-19	Alkermes Pharma Ireland Limited	Pharmazeutische zusammensetzungen mit verbesserter lagerstabilität
US9375433B2 (en)	2012-09-26	2016-06-28	Tangent Reprofiling Limited	Modulators of androgen synthesis
NZ706067A (en) *	2012-09-26	2016-07-29	Tangent Reprofiling Ltd	Modulators of androgen synthesis
BR112016021535A8 (pt)	2014-03-20	2021-07-20	Alkermes Pharma Ireland Ltd	kit compreendendo formulações de aripiprazol tendo velocidades de injeção aumentadas útil para o tratamento de uma desordem do sistema nervoso central e uso
CN106831594B (zh) *	2017-01-18	2018-02-02	力赛生物医药科技（厦门）有限公司	可乐定双羟萘酸盐及其制备方法
EP3761983A1 (de)	2018-03-05	2021-01-13	Alkermes Pharma Ireland Limited	Dosierstrategie für aripiprazol
WO2023160583A1 (zh) *	2022-02-22	2023-08-31	上海云晟研新生物科技有限公司	卡利拉嗪药用盐及其晶型、药物组合物、制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4352811A (en) *	1981-11-12	1982-10-05	Hoechst-Roussel Pharmaceuticals Inc.	3-(1-Substituted-4-piperidyl)-1,2-benzisoxazoles
US4452799A (en) *	1981-12-23	1984-06-05	Mead Johnson & Company	Benzisothiazole and benzisoxazole piperazine derivatives
US4485107A (en) *	1982-11-01	1984-11-27	Janssen Pharmaceutica N.V.	[[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones
US4588722A (en) *	1984-01-09	1986-05-13	Janssen Pharmaceutica N.V.	N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives
US4804663A (en) *	1985-03-27	1989-02-14	Janssen Pharmaceutica N.V.	3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
GB9008850D0 (en) *	1990-04-19	1990-06-13	Janssen Pharmaceutica Nv	Novel 2,9-disubstituted-4h-pyridol(1,2-a)pyrimidin-4-ones

1994
- 1994-03-31 TW TW083102808A patent/TW376319B/zh not_active IP Right Cessation
- 1994-04-08 PH PH48074A patent/PH30476A/en unknown
- 1994-04-22 RO RO95-01879A patent/RO115955B1/ro unknown
- 1994-04-22 ES ES94915538T patent/ES2113652T3/es not_active Expired - Lifetime
- 1994-04-22 RU RU95119831A patent/RU2131428C1/ru active
- 1994-04-22 CA CA002160366A patent/CA2160366C/en not_active Expired - Lifetime
- 1994-04-22 PL PL94311282A patent/PL182466B1/pl unknown
- 1994-04-22 NZ NZ266143A patent/NZ266143A/en not_active IP Right Cessation
- 1994-04-22 US US08/522,422 patent/US5612346A/en not_active Expired - Lifetime
- 1994-04-22 CN CN94191934A patent/CN1041727C/zh not_active Expired - Lifetime
- 1994-04-22 SI SI9420031A patent/SI9420031B/sl unknown
- 1994-04-22 SG SG1996004131A patent/SG47046A1/en unknown
- 1994-04-22 KR KR1019950704171A patent/KR100307101B1/ko not_active Expired - Lifetime
- 1994-04-22 SK SK1313-95A patent/SK280589B6/sk not_active IP Right Cessation
- 1994-04-22 WO PCT/EP1994/001296 patent/WO1994025460A1/en not_active Ceased
- 1994-04-22 JP JP52386294A patent/JP3478397B2/ja not_active Expired - Lifetime
- 1994-04-22 DE DE69408666T patent/DE69408666T2/de not_active Expired - Lifetime
- 1994-04-22 CZ CZ19952706A patent/CZ286688B6/cs not_active IP Right Cessation
- 1994-04-22 AT AT94915538T patent/ATE163418T1/de active
- 1994-04-22 HU HU9501934A patent/HU218212B/hu unknown
- 1994-04-22 EP EP94915538A patent/EP0697019B1/de not_active Expired - Lifetime
- 1994-04-22 AU AU67216/94A patent/AU675136B2/en not_active Expired
- 1994-04-22 DK DK94915538T patent/DK0697019T3/da active
- 1994-04-26 ZA ZA942909A patent/ZA942909B/xx unknown
- 1994-04-27 IL IL109448A patent/IL109448A/xx not_active IP Right Cessation
1995
- 1995-10-25 BG BG100094A patent/BG62004B1/bg unknown
- 1995-10-26 NO NO954275A patent/NO305083B1/no not_active IP Right Cessation
- 1995-10-27 FI FI955166A patent/FI109125B/fi not_active IP Right Cessation
1996
- 1996-12-24 US US08/773,737 patent/US5723467A/en not_active Expired - Lifetime
1998
- 1998-02-26 GR GR980400198T patent/GR3026028T3/el unknown
- 1998-06-16 CY CY9800009A patent/CY2107B1/xx unknown
1999
- 1999-02-24 LV LVP-99-32A patent/LV12315B/en unknown

Also Published As

Publication number	Publication date
US5612346A (en)	1997-03-18
NO954275L (no)	1995-10-26
US5723467A (en)	1998-03-03
EP0697019B1 (de)	1998-02-25
FI955166L (fi)	1995-10-27
SK131395A3 (en)	1996-06-05
PL311282A1 (en)	1996-02-05
DK0697019T3 (da)	1998-09-28
IL109448A0 (en)	1994-07-31
CN1121719A (zh)	1996-05-01
ATE163418T1 (de)	1998-03-15
JPH08509482A (ja)	1996-10-08
DE69408666T2 (de)	1998-06-18
BG100094A (bg)	1996-05-31
HK1006059A1 (en)	1999-02-05
LV12315A (lv)	1999-07-20
NZ266143A (en)	1996-07-26
ES2113652T3 (es)	1998-05-01
JP3478397B2 (ja)	2003-12-15
NO954275D0 (no)	1995-10-26
SG47046A1 (en)	1998-03-20
TW376319B (en)	1999-12-11
CZ270695A3 (en)	1996-01-17
RO115955B1 (ro)	2000-08-30
RU2131428C1 (ru)	1999-06-10
HU9501934D0 (en)	1995-09-28
SI9420031B (sl)	2002-08-31
HUT72970A (en)	1996-06-28
EP0697019A1 (de)	1996-02-21
IL109448A (en)	1997-03-18
WO1994025460A1 (en)	1994-11-10
CN1041727C (zh)	1999-01-20
FI109125B (fi)	2002-05-31
AU675136B2 (en)	1997-01-23
PL182466B1 (pl)	2002-01-31
KR100307101B1 (ko)	2001-11-30
CY2107B1 (en)	2002-04-26
BG62004B1 (bg)	1998-12-30
AU6721694A (en)	1994-11-21
GR3026028T3 (en)	1998-04-30
LV12315B (en)	2000-03-20
CZ286688B6 (en)	2000-06-14
ZA942909B (en)	1995-10-26
HU218212B (hu)	2000-06-28
SI9420031A (en)	1996-08-31
FI955166A0 (fi)	1995-10-27
CA2160366A1 (en)	1994-11-10
SK280589B6 (sk)	2000-04-10
CA2160366C (en)	2006-06-06
NO305083B1 (no)	1999-03-29
DE69408666D1 (de)	1998-04-02

Publication	Publication Date	Title
CY2107B1 (en)	2002-04-26	Risperidone pamoate
FR05C0045I2 (de)	2007-08-03
GR3022510T3 (en)	1997-05-31	Lyospheres comprising gonadotropin
PL310171A1 (en)	1995-11-27	Novel imidazopyridines
HU9501719D0 (en)	1995-08-28	Polypeptide and anti-hiv agent prepared therefrom
HRP940271A2 (en)	1996-12-31	Intermediate for azithromycin
GB9126725D0 (en)	1992-02-12	Process
ZA938414B (en)	1995-05-11	Substituted ortho-ethenylphenylacetic acid derivatives
TW248530B (de)	1995-06-01
TW261516B (de)	1995-11-01
ZA939227B (en)	1995-06-09	Novel triazoloquinazolines,their preparation and use
AU1466592A (en)	1992-11-17	Gem-diphosphonic acid nitrosocarbamoyl derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
AU675281B2 (en)	1997-01-30	Application of riluzole as a radiorestorer